ApoE genotyping as a progression-rate biomarker in phase II disease-modification trials for Alzheimer's disease

D. J. Stone, C. Molony, C. Suver, E. E. Schadt, W. Z. Potter

Research output: Contribution to journalShort surveypeer-review

16 Scopus citations
Original languageEnglish
Pages (from-to)161-164
Number of pages4
JournalPharmacogenomics Journal
Issue number3
StatePublished - Jun 2010
Externally publishedYes

Cite this